New patent expiry for Branded drug Teva PROAIR DIGIHALER – DrugPatentWatch
Annual Drug Patent Expiration for PROAIR+DIGIHALER
Proair Digihaler is a drug marketed by Teva Branded Pharm and included in one NDA. It is available from a single supplier. There are twenty-two patents protecting this drug.
Price trends for PROAIR DIGIHALER drugs.
Drug patent litigation for PROAIR DIGIHALER.
This drug has three hundred and eighty-six patent family members in thirty-one countries.
The generic ingredient in PROAIR DIGIHALER is albuterol sulfate. One registered supplier for this compound. Additional details are available on the albuterol sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published when the new Patent expired for the drug Teva Branded PROAIR DIGIHALER
